Factors influencing quality of life of people living with HIV in Estonia: a cross-sectional survey

Kristi Rüütel, Heti Pisarev, Helle-Mai Loit, Anneli Uusküla, Kristi Rüütel, Heti Pisarev, Helle-Mai Loit, Anneli Uusküla

Abstract

Background: Identification of factors that determine quality of life is important in order to better tailor health and social care services, and thereby improve the functioning and well being of people living with HIV. The estimated number of people living with HIV in eastern Europe and central Asia is 1.6 million. Little is known about the quality of life of people living with HIV in this region. The main purpose of the present study was to identify the factors influencing quality of life in a sample of HIV-infected persons in Estonia.

Methods: A convenient sample of 451 patients attending three infectious diseases clinics for routine HIV clinical care visits was recruited for a cross-sectional survey. The World Health Organization's Quality of Life HIV instrument was used to measure quality of life of the participants and medical data was abstracted from clinical records.

Results: Good overall quality of life was reported by 42.6% (95% CI: 38.0-47.2%) of the study participants (53% men, 60% self-identify as injecting drug users, 82% <30 years of age, 30% with CD4+ T cell count <300 cells/mm3, and 22% on antiretroviral treatment). We identified the following variables as independent predictors of good overall quality of life: being currently employed or studying (AOR: 2.27, 95% CI: 1.18-4.38); and the absence of HIV-related symptoms (AOR: 2.31, 95% CI: 1.24-4.29).

Conclusion: A comprehensive and competent care system, including health care providers and social workers, is required for an effective response. In addition, social interventions should seek to enhance the economic and employment opportunities for people living with HIV in the region.

References

    1. McDonnell KA, Gielen AC, O'Campo P, Burke JG. Abuse, HIV status and health-related quality of life among a sample of HIV positive and HIV negative low income women. Quality of Life Research. 2005;12:945–957. doi: 10.1007/s11136-004-3709-z.
    1. Cowdery JE, Pesa JA. Assessing quality of life in women living with HIV infection. AIDS Care. 2002;12(2):235–245. doi: 10.1080/09540120220104730.
    1. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrument. Ann Intern Med. 1992;12:129–137.
    1. Murri R, Fantoni M, Del Borgo C, Visona R, Barracco A, Zambelli A, Testa L, Orchi N, Tozzi V, Bosco O, Wu AW. Determinants of health-related quality of life in HIV-infected patients. AIDS Care. 2003;12(4):581–590. doi: 10.1080/0954012031000134818.
    1. Rüütel K, Uusküla A. HIV epidemic in Estonia in the third decade of AIDS era. Scandinavian Journal of Infectious Diseases. 2005;12:181–186. doi: 10.1080/00365540500388743.
    1. UNAIDS/WHO. AIDS Epidemic Update. Geneva. 2007.
    1. EuroHIV. HIV/AIDS Surveillance in Europe. Mid-year report. 2007.
    1. Database of Statistical Office of Estonia.
    1. Database of Estonian Health Protection Inspectorate.
    1. Database of National Institute for Health Development.
    1. Rüütel K, Uusküla A, Minossenko A, Loit HM. Quality of life of people living with HIV and AIDS in Estonia. Cent Eur J Public Health. 2008;12(3):111–115.
    1. Rüütel K, Loit HM, Uusküla A. Psychometric properties of Russian version of WHOQOL-HIV instrument. The 5th European Conference on Clinical and Social Research on AIDS and Drugs: 28–30 April 2009; Vilnius, Lithuania. Abstract no PE3.3/7.
    1. WHOQOL-HIV Group. Preliminary development of the World Health Organization's Quality of Life HIV Instrument (WHOQOL-HIV): analysis of the pilot version. Social Science and Medicine. 2003;12:1259–1275. doi: 10.1016/S0277-9536(02)00506-3.
    1. Preau M, Protopopescu C, Spire B, Sobel A, Dellamonica P, Moatti JP, Carrieri MP. Health related quality of life among both current and former injection drug users who are HIV-infected. Drug Alcohol Depend. . 2007;12(2-3):175–182. doi: 10.1016/j.drugalcdep.2006.06.012.
    1. Costenbader EC, Zule WA, Coomes CM. The impact of illicit drug use and harmful drinking on quality of life among injection drug users at high risk for hepatitis C infection. Drug Alcohol Depend. . 2007;12(2-3):251–258. doi: 10.1016/j.drugalcdep.2007.01.006.
    1. Galea S, Vlahov D. Social determinants and the health of drug users: socioeconomic status, homelessness, and incarceration. Public Health Rep. 2002;12(Suppl 1):S135–145.
    1. Blalock AC, MacDaniel JS, Farber EW. Effect of employment on quality of life and psychological functioning in patients with HIV/AIDS. Psychosomatics. 2002;12:400–404. doi: 10.1176/appi.psy.43.5.400.
    1. Worthington C, Krentz HB. Socio-economic factors and health-related quality of life in adults living with HIV. International Journal of STD & AIDS. 2005;12(9):608–614. doi: 10.1258/0956462054944408.
    1. Low-Beer S, Chan K, Wood E, Yip B, Montaner JS, O'Shaughnessy MV, Hogg RS. Health related quality of life among persons with HIV after the use of protease inhibitors. Quality of Life Research. 2000;12:941–949. doi: 10.1023/A:1008985728271.
    1. Mrus JM, Leonard AC, Yi MS, Sherman SN, Fultz SL, Justice AC, Tsevat J. Health-related quality of life in veterans and nonveterans with HIV/AIDS. J Gen Intern Med. 2006;12:S39–47. doi: 10.1111/j.1525-1497.2006.00644.x.
    1. Sowell RL, Seals BF, Moneyham L, Demi A, Cohen L, Brake S. Quality of life in HIV-infected women in the south-eastern United States. AIDS Care . 1997;12(5):501–512.
    1. Carballo E, Cadarso-Suarez C, Carrera I, Fraga J, de la Fuente J, Ocampo A, Ojea R, Prieto A. Assessing relationships between health-related quality of life and adherence to antiretroviral therapy. Quality of Life Research. 2004;12:587–599. doi: 10.1023/B:QURE.0000021315.93360.8b.
    1. Cohen C, Revicki DA, Nabulsi A, Sarocco PW, Jiang P. the Advanced HIV Disease Ritonavir Study Group. A randomized trial of the effect of ritonavir in maintaining quality of life in advanced HIV disease. AIDS. 1998;12:1495–1502. doi: 10.1097/00002030-199812000-00012.
    1. Nieuwkerk PT, Gisolf EH, Reijers MHE, Lange JMA, Danner SA, Sprangers MAG. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS. 2001;12:1985–1991. doi: 10.1097/00002030-200110190-00011.
    1. Tefanova V, Tallo T, Kutsar K, Priimägi L. Current trends in the epidemiology of viral hepatitis B and C in Estonia. EpiNorth. 2005;12(6):57–61.
    1. Uusküla A, McNutt LA, Dehovitz J, Fischer K, Heimer R. High prevalence of blood-borne virus infections and high-risk behaviour among injecting drug users in Tallinn, Estonia. Int J STD AIDS. 2007;12(1):41–46. doi: 10.1258/095646207779949907.
    1. Foster G, Goldin R, Thomas H. Chronic hepatitis C virus infection causes a significant reduction in quality of life. Hepatology. 1998;12:209–212. doi: 10.1002/hep.510270132.
    1. Bonkovsky HL, Wooley JM. The Consensus Interferon Study Group. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology. 1999;12:264–210. doi: 10.1002/hep.510290124.
    1. Bonkovsky HL, Snow KK, Malet PF, Back-Madruga C, Fontana RJ, Sterling RK, Kulig CC, Di Bisceglie AM, Morgan TR, Dienstag JL, Ghany MG, Gretch DR. HALT-C Trial Group. Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis. J Hepatol. . 2007;12(3):420–431. doi: 10.1016/j.jhep.2006.10.009.
    1. Herdman MJ, Ossa D, Briggs AS, Tafesse E, Iloeje U, Lozano-Ortega G, Levy AR. Impact on quality of life of health states induced by chronic hepatitis B infection: estimates from uninfected and infected persons in Spain. J Clin Virology. 2006;12(Suppl 2):S78. doi: 10.1016/S1386-6532(06)80238-6.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren